Unknown

Dataset Information

0

C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells.


ABSTRACT: The objective of this study was to determine the effects and potential mechanisms of C-reactive protein (CRP) on cholesterol efflux from human macrophage foam cells, which may play a critical role in atherogenesis.Human THP-1 monocytes and peripheral blood mononuclear cells (PBMCs) were preincubated with acetylated LDL and [3H]-cholesterol to form foam cells, which were then treated with apolipoprotein A-I (apoA-I) or HDL for cholesterol efflux assay. Clinically relevant concentrations of CRP significantly reduced cholesterol efflux from THP-1 and PBMCs to apoA-I or HDL. CRP significantly decreased the expression of ATP-binding membrane cassette transporter A-1 (ABCA1) and ABCG1, whereas it increased superoxide anion production. Furthermore, CRP substantially activated ERK1/2 in THP-1-derived foam-like cells. Reducing superoxide anion by antioxidant seleno-L-methionine or SOD mimetic (MnTBAP) effectively abolished the CRP-induced decrease in cholesterol efflux and the expression of ABCA1 and ABCG1. Inhibiting ERK1/2 activation by its specific inhibitor PD98059 or by a dominant negative mutant of ERK2 could also block CRPs action on THP-1 cells.CRP inhibits cholesterol efflux from human foam cells derived from THP-1 and PBMCs in vitro though oxidative stress, ERK1/2 activation, and downregulation of intracellular cholesterol transport molecules ABCA1 and ABCG1.

SUBMITTER: Wang X 

PROVIDER: S-EPMC2927966 | BioStudies | 2008-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5731260 | BioStudies
1000-01-01 | S-EPMC2066200 | BioStudies
1000-01-01 | S-EPMC6217053 | BioStudies
1000-01-01 | S-EPMC3276468 | BioStudies
2010-01-01 | S-EPMC2925122 | BioStudies
1000-01-01 | S-EPMC3520537 | BioStudies
2012-01-01 | S-EPMC3697153 | BioStudies
2009-01-01 | S-EPMC2787635 | BioStudies
1000-01-01 | S-EPMC5057233 | BioStudies
2012-01-01 | S-EPMC3262074 | BioStudies